Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    "Eales disease"
Show Display Options
Rank Status Study
1 Completed Lucentis (Ranibizumab) for Eales' Disease
Condition: Eales' Disease
Intervention: Drug: Ranibizumab

Indicates status has not been verified in more than two years